Literature DB >> 22563843

GPR18 in microglia: implications for the CNS and endocannabinoid system signalling.

D McHugh1.   

Abstract

A review of what is presently known about the G protein coupled receptor GPR18 in terms of its expression and distribution, pharmacology and potential implications for central nervous system and endocannabinoid system signalling. LINKED ARTICLES This article is part of a themed section on Cannabinoids. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.167.issue-8.
© 2012 The Author. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22563843      PMCID： PMC3525861          DOI： 10.1111/j.1476-5381.2012.02019.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  52 in total

1.  So what do we call GPR18 now?

Authors:  S P H Alexander
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 2.  Microglia and the pathogenesis of spongiform encephalopathies.

Authors:  P Rezaie; P L Lantos
Journal:  Brain Res Brain Res Rev       Date:  2001-03

3.  The G protein-coupled receptor repertoires of human and mouse.

Authors:  Demetrios K Vassilatis; John G Hohmann; Hongkui Zeng; Fusheng Li; Jane E Ranchalis; Marty T Mortrud; Analisa Brown; Stephanie S Rodriguez; John R Weller; Abbie C Wright; John E Bergmann; George A Gaitanaris
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

Review 4.  Modulation of transmitter release via presynaptic cannabinoid receptors.

Authors:  E Schlicker; M Kathmann
Journal:  Trends Pharmacol Sci       Date:  2001-11       Impact factor: 14.819

5.  Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes.

Authors:  N E Berman; J K Marcario; C Yong; R Raghavan; L A Raymond; S V Joag; O Narayan; P D Cheney
Journal:  Neurobiol Dis       Date:  1999-12       Impact factor: 5.996

6.  Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

Authors:  Lisa Walter; Allyn Franklin; Anke Witting; Christian Wade; Yiheng Xie; George Kunos; Ken Mackie; Nephi Stella
Journal:  J Neurosci       Date:  2003-02-15       Impact factor: 6.167

7.  Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

Authors:  László Offertáler; Fong-Ming Mo; Sándor Bátkai; Jie Liu; Malcolm Begg; Raj K Razdan; Billy R Martin; Richard D Bukoski; George Kunos
Journal:  Mol Pharmacol       Date:  2003-03       Impact factor: 4.436

Review 8.  Cannabinoid receptors and their ligands.

Authors:  R G Pertwee; R A Ross
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

9.  Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors.

Authors:  Allyn Franklin; Nephi Stella
Journal:  Eur J Pharmacol       Date:  2003-08-08       Impact factor: 4.432

Review 10.  Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease.

Authors:  Benjamin M Segal
Journal:  Curr Allergy Asthma Rep       Date:  2003-01       Impact factor: 4.919
View more
  28 in total

1.  Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.

Authors:  Linda Console-Bram; Eugen Brailoiu; Gabriela Cristina Brailoiu; Haleli Sharir; Mary E Abood
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

2.  2012 cannabinoid themed section.

Authors:  Stephen P H Alexander
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.

Authors:  Julia Park; Christopher J Langmead; Darren M Riddy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-20

5.  The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.

Authors:  Anusha Penumarti; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2014-01-15       Impact factor: 4.030

6.  N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways.

Authors:  Van B Lu; Henry L Puhl; Stephen R Ikeda
Journal:  Mol Pharmacol       Date:  2012-10-25       Impact factor: 4.436

Review 7.  Molecular Targets of Cannabidiol in Neurological Disorders.

Authors:  Clementino Ibeas Bih; Tong Chen; Alistair V W Nunn; Michaël Bazelot; Mark Dallas; Benjamin J Whalley
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

8.  Lysophosphatidylinositol, an Endogenous Ligand for G Protein-Coupled Receptor 55, Has Anti-inflammatory Effects in Cultured Microglia.

Authors:  Tomoki Minamihata; Katsura Takano; Mitsuaki Moriyama; Yoichi Nakamura
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 9.  Microglia during development and aging.

Authors:  G Jean Harry
Journal:  Pharmacol Ther       Date:  2013-04-30       Impact factor: 12.310

10.  N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.

Authors:  Alexander I Bondarenko; Konstantin Drachuk; Olga Panasiuk; Vadim Sagach; Andras T Deak; Roland Malli; Wolfgang F Graier
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.